NDC 50742-624

Lamivudine

Lamivudine

Lamivudine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Ingenus Pharmaceuticals, Llc. The primary component is Lamivudine.

Product ID50742-624_723a8db6-baa2-47f7-a352-0ed4c25a184e
NDC50742-624
Product TypeHuman Prescription Drug
Proprietary NameLamivudine
Generic NameLamivudine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2017-02-01
Marketing CategoryANDA / ANDA
Application NumberANDA206974
Labeler NameIngenus Pharmaceuticals, LLC
Substance NameLAMIVUDINE
Active Ingredient Strength300 mg/1
Pharm ClassesHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50742-624-60

30 TABLET in 1 BOTTLE, PLASTIC (50742-624-60)
Marketing Start Date2017-02-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50742-624-30 [50742062430]

Lamivudine TABLET
Marketing CategoryANDA
Application NumberANDA206974
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-02-01
Marketing End Date2018-12-14

NDC 50742-624-60 [50742062460]

Lamivudine TABLET
Marketing CategoryANDA
Application NumberANDA206974
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-02-01

Drug Details

Active Ingredients

IngredientStrength
LAMIVUDINE300 mg/1

OpenFDA Data

SPL SET ID:47f8be59-178c-4bad-96a4-a5c82784f308
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 199147
  • 349491
  • UPC Code
  • 0350742623600
  • Pharmacological Class

    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    Medicade Reported Pricing

    50742062430 LAMIVUDINE 300 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Lamivudine" or generic name "Lamivudine"

    NDCBrand NameGeneric Name
    0904-6583LAMIVUDINElamivudine
    10135-605LamivudineLamivudine
    31722-001lamivudinelamivudine
    31722-752LamivudineLamivudine
    31722-753LamivudineLamivudine
    31722-754LamivudineLamivudine
    33342-001LamivudineLamivudine
    33342-002LamivudineLamivudine
    68180-603LamivudineLamivudine
    68180-602LamivudineLamivudine
    69097-167LAMIVUDINELAMIVUDINE
    69097-166LAMIVUDINELAMIVUDINE
    70518-0540LamivudineLamivudine
    70518-0440LamivudineLamivudine
    70518-0513LamivudineLamivudine
    70518-0690LamivudineLamivudine
    70518-1083LamivudineLamivudine
    70518-1084LamivudineLamivudine
    70518-1634LamivudineLamivudine
    70518-1933LamivudineLamivudine
    50268-460LamivudineLamivudine
    50268-459LamivudineLamivudine
    50742-623LamivudineLamivudine
    50742-624LamivudineLamivudine
    51293-832LamivudineLamivudine
    53808-0843LAMIVUDINELAMIVUDINE
    53808-0844LAMIVUDINELAMIVUDINE
    54838-566LamivudineLamivudine
    57237-274LamivudineLamivudine
    60429-354LAMIVUDINELAMIVUDINE
    60687-362LamivudineLamivudine
    60429-353LAMIVUDINELAMIVUDINE
    60505-3250LamivudineLamivudine
    60505-3252LAMIVUDINELAMIVUDINE
    60505-3251LAMIVUDINELAMIVUDINE
    63629-5014LamivudineLamivudine
    64380-711LamivudineLamivudine
    64330-001LamivudineLamivudine
    64380-710LamivudineLamivudine
    65862-055LamivudineLamivudine
    65862-026LamivudineLamivudine
    65862-552LamivudineLamivudine
    65862-553LamivudineLamivudine
    65862-025LamivudineLamivudine
    66993-478LamivudineLamivudine
    69967-003LamivudineLamivudine
    69967-004LamivudineLamivudine
    70518-2067LamivudineLamivudine
    70518-2070LamivudineLamivudine
    0173-0662EPIVIRlamivudine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.